Temporal patterns of left ventricular systolic and diastolic metrics changes in adult patients with haematological malignancies treated with chimeric antigen receptor (CAR)-T cells: results from the CARdio-Tox prospective study-Reference-Cited by-同舟云学术

Temporal patterns of left ventricular systolic and diastolic metrics changes in adult patients with haematological malignancies treated with chimeric antigen receptor (CAR)-T cells: results from the CARdio-Tox prospective study

Published:2023-11-19 Issue: Volume: Page:
ISSN:2047-2404
Container-title:European Heart Journal - Cardiovascular Imaging
language:en
Short-container-title:

Author:

Camilli Massimiliano¹²^ORCID,Lombardo Antonella¹²,Crea Filippo¹²,Minotti Giorgio³⁴

Affiliation:

1. Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Largo Francesco Vito, 1-00168 Rome , Italy

2. Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS , Largo Agostino Gemelli , 1–00168 Rome, Italy

3. Department of Medicine, University Campus Bio-Medico , Rome , Italy

4. Fondazione Policlinico Universitario Campus Bio-Medico , Rome , Italy

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://academic.oup.com/ehjcimaging/advance-article-pdf/doi/10.1093/ehjci/jead317/53959861/jead317.pdf

Reference5 articles.

1. Chimeric antigen receptor T-cell therapy for hematologic malignancies: a practical review;Strati;JCO Oncol Pract,2023

2. Toxicities of chimeric antigen receptor T cells: recognition and management;Brudno;Blood,2016

3. Cardiotoxicity of T-cell antineoplastic therapies: JACC: CardioOncology primer;Ganatra;JACC CardioOncol,2022

4. Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T);Alvi;J Am Coll Cardiol,2019

5. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS);Lyon;Eur Heart J,2022